Target intelligence / Profile preview

Extracellular matrix of wound bed (ECM)

Target
ECM
Molecular classification
Structural protein complex, Glycoprotein, Proteoglycan, Extracellular matrix component
01

Overview

The extracellular matrix (ECM) of the wound bed is a complex, dynamic network of proteins and polysaccharides, including collagen, fibronectin, and laminin, that provides the structural framework for tissue repair (Olczyk et al., 2014, PMID: 24644448). It functions as a reservoir for signaling molecules and growth factors, regulating cellular processes such as adhesion, migration, and differentiation during the inflammatory, proliferative, and remodeling phases of healing (Schultz et al., 2011, PMID: 21908271). In chronic wounds, the ECM is often compromised by an imbalance of matrix metalloproteinases (MMPs) and their inhibitors, leading to premature degradation of the scaffold and stalled healing (Gibson et al., 2009, PMID: 19320595). Therapeutic strategies targeting the wound bed ECM include enzymatic debridement with agents like collagenase to remove necrotic tissue and the application of bioengineered scaffolds to restore structural integrity (Pruitt et al., 2008, PMID: 18354341). Additionally, advanced dressings are designed to modulate the ECM environment by sequestering excess proteases or delivering exogenous matrix components to stimulate endogenous repair mechanisms (Boateng et al., 2008, PMID: 18543331).

Other names
Wound ECMGranulation tissue matrixProvisional matrixDermal extracellular matrixWound bed microenvironment
02

Mechanism of action

Enzymatic degradation of denatured collagen to facilitate debridement, provision of structural scaffolds for cellular infiltration, and modulation of the protease environment to promote the transition from the inflammatory to the proliferative phase of healing (Schultz et al., 2011, PMID: 21908271).

03

Biological functions

Cell adhesionCell migrationTissue remodelingSignal transductionGrowth factor sequestrationStructural support
04

Disease associations

Chronic woundDiabetic foot ulcerPressure ulcerVenous leg ulcerFibrosisHypertrophic scarring
05

Safety considerations

Hypersensitivity to animal-derived matrix componentsLocalized irritation or pain at the application siteRisk of excessive granulation tissue formationPotential for systemic absorption of enzymatic debriding agents
06

Interacting drugs

Collagenase clostridium histolyticum

4 more in the full profile.

07

Biomarkers

Matrix metalloproteinase-9 (MMP-9)Tissue inhibitor of metalloproteinases-1 (TIMP-1)HydroxyprolineWound fluid pHLactate levels

Beyond the preview

Go deeper on Extracellular matrix of wound bed (ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix of wound bed (ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call